Zim Laboratories Ltd. (ZIMLAB): Zim Laboratories Share Price Rises 11.31% Today
- September 2, 2026
- Posted by: Harsh Piplani
- Category: News
Zim Laboratories rose to Rs 132.35, up 11.31% today. Market capitalisation stood at Rs 663.49 crore.
Zim Laboratories Share Price moved to Rs 132.35 on 02 September 2026, up Rs 13.45 or 11.31% from the previous close of Rs 118.9. The stock opened at Rs 112, touched a high of Rs 133.1 and a low of Rs 112, with turnover at Rs 0.11 crore. The data confirms a sharp same-day move, but it does not identify any company-specific trigger. So the best way to read the rise is through the available numbers: price action, valuation, profitability, industry benchmarks and peer comparison.
The company operates in Healthcare under Pharmaceuticals & Drugs, and its market capitalisation stood at Rs 663.49 crore. For readers tracking Zim Laboratories Share Price today, the key question is not just that the stock jumped, but how that move sits against earnings, book value and sector metrics. On the supplied data, valuation looks rich on earnings while profitability remains below broader industry medians.
Zim Laboratories Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 132.35 |
| Previous Close | Rs 118.9 |
| Today's Move | Rs 13.45 (+11.31%) |
| Open | Rs 112 |
| High | Rs 133.1 |
| Low | Rs 112 |
| Turnover | Rs 0.11 crore |
| Market Capitalisation | Rs 663.49 crore |
| Market Cap Category | Micro Cap |
Zim Laboratories Ltd. (ZIMLAB) rose to Rs 132.35 from the previous close of Rs 118.9, a move of Rs 13.45 or 11.31%. The stock opened at Rs 112, reached a high of Rs 133.1, recorded a low of Rs 112.
The session was volatile but clearly positive. ZIMLAB opened at Rs 112, which was also the day’s low, and then rallied to Rs 133.1 before trading at Rs 132.35 near the upper end of the range. Against the previous close of Rs 118.9, that means a gain of Rs 13.45 or 11.31%.
This intraday pattern matters because it shows that buyers pushed the stock sharply higher from the open and kept it close to the day high by the time of the update. Turnover was Rs 0.11 crore, so the rise came on relatively modest traded value compared with much larger pharma names. Even so, the move was large enough to place the stock among notable gainers in its segment.
From a market-data perspective, the day’s numbers are straightforward: current price Rs 132.35, previous close Rs 118.9, open Rs 112, high Rs 133.1, low Rs 112, turnover Rs 0.11 crore and market cap Rs 663.49 crore.
Zim Laboratories Ltd. (ZIMLAB) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 663.49 crore |
| P/E Ratio | 172.62x |
| P/B Ratio | 2.2x |
| ROE | 2.14% |
| ROCE | 5.47% |
| EPS | Rs 0.69 |
| Book Value Per Share | Rs 54.16 |
| Dividend Yield | 0% |
Zim Laboratories Ltd. (ZIMLAB) fundamental metrics show P/E 172.62x, P/B 2.2x, ROE 2.14%, ROCE 5.47%. These figures provide context only and are not a buy or sell signal.
Zim Laboratories Ltd. has a market capitalisation of Rs 663.49 crore and falls in the Micro Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 172.62x, P/B at 2.2x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 2.14% and ROCE of 5.47%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 0.69, book value per share of Rs 54.16, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 31.29x, median ROE of 11.79%, median ROCE of 13.63%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 172.62x |
| Benchmark Median P/E | 31.29x |
| Benchmark Average P/E | 48.12x |
| Benchmark P/E Range | 3.68x to 653.31x |
| Company P/B Ratio | 2.2x |
| Benchmark Median P/B | 2.88x |
| Company ROE | 2.14% |
| Benchmark Median ROE | 11.79% |
| Company ROCE | 5.47% |
| Benchmark Median ROCE | 13.63% |
| Company Market Capitalisation | Rs 663.49 crore |
| Benchmark Median Market Cap | Rs 720.34 crore |
Zim Laboratories Ltd. (ZIMLAB) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Zim Laboratories Ltd. (ZIMLAB) has a P/E ratio of 172.62x, which is above the benchmark median of 31.29x, a difference of +451.68%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Zim Laboratories Ltd. (ZIMLAB) has a ROE of 2.14%, which is below the benchmark median of 11.79%, a difference of -81.85%. Zim Laboratories Ltd. (ZIMLAB) has a ROCE of 5.47%, which is below the benchmark median of 13.63%, a difference of -59.87%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,69,309.92 | 38.29 | 5.36 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,45,425.7 | 83.18 | 13.77 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,89,347.12 | 86.48 | 21.02 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,15,919.92 | 25.73 | 4.31 | 19.69 | 21.39 |
| Cipla Ltd. | CIPLA | 1,14,392.76 | 33.99 | 3.26 | 11.83 | 16 |
Zim Laboratories Ltd. (ZIMLAB) has a P/E ratio of 172.62x compared with the displayed peer median of 38.29x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 2.14% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 5.47% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Zim Laboratories Ltd. (ZIMLAB) has a market capitalisation of Rs 663.49 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching Zim Laboratories
- Strong move: The stock rose 11.31% to Rs 132.35, up Rs 13.45 from Rs 118.9.
- Intraday strength: It opened at Rs 112 and touched Rs 133.1.
- Valuation gap: P/E of 172.62 is above the industry median of 31.29 and average of 48.12.
- Profitability gap: ROE of 2.14 and ROCE of 5.47 are below industry medians of 11.79 and 13.63.
- Peer contrast: The stock is far smaller than major pharma peers but trades at a higher earnings multiple.
About Zim Laboratories
Zim Laboratories Ltd. is a listed Healthcare company in the Pharmaceuticals & Drugs industry. The master data was matched, with coverage marked as matched by finCode.
Within the market context, the stock is best understood through its current trading data and peer positioning rather than any stated event catalyst, since none was supplied.
Track Zim Laboratories Share Price on Univest
Use Zim Laboratories Ltd. (ZIMLAB) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Readers can follow Zim Laboratories Share Price on the Zim Laboratories Ltd. (ZIMLAB) live share-price page. For broader market context, use the Univest top gainers screener and Univest market blogs.
For now, the verified takeaway is simple: Zim Laboratories Share Price rose 11.31% to Rs 132.35. The data does not confirm why the stock rose, but it does show a sharp price move alongside high P/E, lower P/B and profitability metrics that trail both industry benchmarks and the displayed large-cap peers.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why is Zim Laboratories Share Price rising today?
Ans. The supplied data shows Zim Laboratories Share Price rose 11.31% to Rs 132.35 from the previous close of Rs 118.9. However, no company-specific catalyst was provided in the dataset. The previous close was Rs 118.9.
What is Zim Laboratories Share Price today?
Ans. Zim Laboratories Share Price stood at Rs 132.35 at the time of the update, with a gain of Rs 13.45 or 11.31% for the session. The previous close was Rs 118.9.
How does Zim Laboratories compare with its industry and peers?
Ans. The company’s P/E is 172.62 versus industry median 31.29 and average 48.12, while ROE of 2.14 and ROCE of 5.47 are below industry medians of 11.79 and 13.63.
